BTG PLC News

Keine aktuellen Kursdaten verfügbar
ISIN: US05581D1072
US-Symbol: BTGYY

BTG PLC News

19.08.19 - PR Newswire
Boston Scientific Closes Acquisition of BTG plc.
Boston Scientific Closes Acquisition of BTG plc. PR Newswire
05.08.19 - PR Newswire
Randomized double-blinded study to commence on DigiFab® for kidney injury related to CABG surgery
Randomized double-​blinded study to commence on DigiFab® for kidney injury related to CABG surgery PR Newswire
02.08.19 - PR Newswire
Magnetar Capital Partners LP - Form 8.3 - BTG PLC
Magnetar Capital Partners LP - Form 8.3 - BTG PLC PR Newswire
01.08.19 - PR Newswire
Magnetar Capital Partners LP - Form 8.3 - BTG PLC
Magnetar Capital Partners LP - Form 8.3 - BTG PLC PR Newswire
31.07.19 - PR Newswire
Magnetar Capital Partners LP - Form 8.3 - BTG PLC
Magnetar Capital Partners LP - Form 8.3 - BTG PLC PR Newswire
30.07.19 - PR Newswire
Magnetar Capital Partners LP - Form 8.3 - BTG PLC
Magnetar Capital Partners LP - Form 8.3 - BTG PLC PR Newswire
29.07.19 - PR Newswire
Magnetar Capital Partners LP - Form 8.3 - BTG PLC
Magnetar Capital Partners LP - Form 8.3 - BTG PLC PR Newswire
26.07.19 - PR Newswire
Magnetar Capital Partners LP - Form 8.3 - BTG PLC
Magnetar Capital Partners LP - Form 8.3 - BTG PLC PR Newswire
26.07.19 - PR Newswire
Magnetar Capital Partners LP - Form 8.3 - BTG PLC
Magnetar Capital Partners LP - Form 8.3 - BTG PLC PR Newswire
23.07.19 - PR Newswire
Recommendations for Personalised HCC Treatment With Y90 TheraSphere™ Published by an International Multidisciplinary Group
Recommendations for Personalised HCC Treatment With Y90 TheraSphere™ Published by an International Multidisciplinary Group Supported by comparative Dosisphere data, a ...
23.07.19 - PR Newswire
Internationale multidisziplinäre Arbeitsgruppe gibt Empfehlungen für personalisierte HCC-Behandlung mit 90-Y TheraSphere™ heraus
Internationale multidisziplinäre Arbeitsgruppe gibt Empfehlungen für personalisierte HCC-​Behandlung mit 90-Y TheraSphere™ heraus PR Newswire
23.07.19 - PR Newswire
Recommendations for Personalised HCC Treatment With Y90 TheraSphere™ Published by an International Multidisciplinary Group
Recommendations for Personalised HCC Treatment With Y90 TheraSphere™ Published by an International Multidisciplinary Group PR Newswire
16.07.19 - PR Newswire
BTG to Invest in Chinese Medical Isotope Diagnosis and Treatment Company Chengdu New Radiomedicine Technology
BTG to Invest in Chinese Medical Isotope Diagnosis and Treatment Company Chengdu New Radiomedicine Technology PR Newswire
16.07.19 - PR Newswire
BTG to Invest in Chinese Medical Isotope Diagnosis and Treatment Company Chengdu New Radiomedicine Technology
BTG to Invest in Chinese Medical Isotope Diagnosis and Treatment Company Chengdu New Radiomedicine Technology PR Newswire
11.07.19 - PR Newswire
NCCN issues first pediatric acute lymphoblastic leukemia guidelines, including use of Voraxaze®
NCCN issues first pediatric acute lymphoblastic leukemia guidelines, including use of Voraxaze® PR Newswire
05.07.19 - PR Newswire
Magnetar Capital Partners LP - Form 8.3 - BTG PLC
Magnetar Capital Partners LP - Form 8.3 - BTG PLC PR Newswire
01.07.19 - PR Newswire
Magnetar Capital Partners LP - Form 8.3 - BTG PLC
Magnetar Capital Partners LP - Form 8.3 - BTG PLC PR Newswire
28.06.19 - PR Newswire
Magnetar Capital Partners LP - Form 8.3 - BTG PLC
Magnetar Capital Partners LP - Form 8.3 - BTG PLC PR Newswire
27.06.19 - PR Newswire
Magnetar Capital Partners LP - Form 8.3 - BTG PLC
Magnetar Capital Partners LP - Form 8.3 - BTG PLC PR Newswire
20.06.19 - PR Newswire
Magnetar Capital Partners LP - Form 8.3 - BTG PLC
Magnetar Capital Partners LP - Form 8.3 - BTG PLC PR Newswire

Newssuche

Videos

26.04.24 +6,31%
Technical Trading: Gold Long freitags
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »